Inventor · disambiguated record
William J. Mcclellan
Also filed as: MCCLELLAN WILLIAM · MCCLELLAN WILLIAM J
32 granted patents·16 pending applications·1,395 citations·filing 1984–2024
98Inventor score
Top patents by PatentIndex Score
48 records- 0198US7973161B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jul 5, 2011·70 cites·5 claims
- 0298US7767684B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Aug 3, 2010·107 cites·7 claims
- 0398US7642260B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Jan 5, 2010·82 cites·2 claims
- 0498US7390799B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jun 24, 2008·331 cites·12 claims
- 0598US6720338B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2001·Granted Apr 13, 2004·98 cites·9 claims
- 0697US8686136B2Apoptosis promotersABBVIE INC·Filed 2012·Granted Apr 1, 2014·20 cites·2 claims
- 0797US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0897US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 0997US8354404B2Apoptosis promotersABBOTT LAB·Filed 2011·Granted Jan 15, 2013·39 cites·8 claims
- 1097US8173811B2Apoptosis promotersBRUNCKO MILAN·Filed 2010·Granted May 8, 2012·50 cites·4 claims
- 1197US7754886B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2009·Granted Jul 13, 2010·34 cites·18 claims
- 1297US7709467B2Apoptosis promotersABBOTT LAB·Filed 2008·Granted May 4, 2010·50 cites·10 claims
- 1397US7504512B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2004·Granted Mar 17, 2009·58 cites·18 claims
- 1496US8614318B2Apoptosis promotersBRUNCKO MILAN·Filed 2006·Granted Dec 24, 2013·37 cites·2 claims
- 1596US8084607B2Apoptosis promotersBRUNCKO MILAN·Filed 2009·Granted Dec 27, 2011·43 cites·5 claims
- 1694US9315488B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2015·Granted Apr 19, 2016·13 cites·2 claims
- 1794US6258822B1Urokinase inhibitorsABBOTT LAB·Filed 1998·Granted Jul 10, 2001·70 cites·5 claims
- 1893US7906505B2Apoptosis promotersABBOTT LAB·Filed 2010·Granted Mar 15, 2011·18 cites·4 claims
- 1990US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 2090US4618683ATetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedativesABBOTT LAB·Filed 1984·Granted Oct 21, 1986·24 cites·17 claims
- 2189US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 2288US2025152600A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 2387US9932340B2Substituted indolesABBVIE INC·Filed 2015·Granted Apr 3, 2018·7 cites·27 claims
- 2487US9296741B2Bromodomain inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·7 cites·61 claims
- 2583US5631401AInhibitors of protein farnesyltransferase and squalene synthaseABBOTT LAB·Filed 1995·Granted May 20, 1997·35 cites·14 claims
- 2680US2023158039A1Bromodomain inhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 2779US9957263B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted May 1, 2018·3 cites·5 claims
- 2877US9321764B2Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2014·Granted Apr 26, 2016·3 cites·25 claims
- 2976US6284796B1Ukokinase inhibitorsABBOTT LAB·Filed 1999·Granted Sep 4, 2001·20 cites·14 claims
- 3075US10131657B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 20, 2018·2 cites·14 claims
- 3173US9994581B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jun 12, 2018·2 cites·22 claims
- 3272US6504031B1Naphthamidine urokinase inhibitorsFiled 2000·Granted Jan 7, 2003·5 cites·2 claims
- 3372US2021236508A1Bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 3469US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 3565US2018296566A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 3661US5389638ATetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitorsABBOTT LAB·Filed 1993·Granted Feb 14, 1995·7 cites·10 claims
- 3761US2018251426A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 3858US2016143916A1Bromodomain inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3956US2019084981A1Bromodomain InhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 4054US2005159427A1N-acylsulfonamide apoptosis promotersFiled 2004·Application pending·0 cites
- 4154US2018193315A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2018·Application pending·0 cites
- 4253US2018071262A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2017·Application pending·0 cites
- 4348US5831115AInhibitors of squalene synthase and protein farnesyltransferaseABBOTT LAB·Filed 1996·Granted Nov 3, 1998·8 cites·35 claims
- 4447US2007135387A1Inhibitors of protein kinasesMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 4547US2016235716A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2015·Application pending·0 cites
- 4644US2016237084A1Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 4741US2001049374A1Urokinase inhibitorsFiled 2001·Application pending·0 cites
- 4836US2002055631A1N-acylsulfonamide apoptosis promotersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William J. Mcclellan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →